Total Payments
$112,207
2024 Payments
$27,400
Companies
56
Transactions
720
Medicare Patients
1,057
Medicare Billing
$134,337
Payment Breakdown by Category
Other$55,126 (49.1%)
Consulting$27,576 (24.6%)
Food & Beverage$16,791 (15.0%)
Travel$12,331 (11.0%)
Education$383.15 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,126 | 43 | 49.1% |
| Consulting Fee | $27,576 | 17 | 24.6% |
| Food and Beverage | $16,791 | 608 | 15.0% |
| Travel and Lodging | $12,331 | 47 | 11.0% |
| Education | $383.15 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $69,411 | 141 | $0 (2024) |
| UCB, Inc. | $14,445 | 53 | $0 (2024) |
| GENZYME CORPORATION | $7,354 | 27 | $0 (2024) |
| ARGENX US, INC. | $4,999 | 18 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $4,470 | 9 | $0 (2024) |
| ABBVIE INC. | $1,276 | 82 | $0 (2024) |
| LivaNova USA, Inc. | $1,112 | 5 | $0 (2023) |
| TG Therapeutics, Inc. | $983.60 | 21 | $0 (2024) |
| Amgen Inc. | $709.71 | 23 | $0 (2024) |
| EMD Serono, Inc. | $676.30 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,400 | 226 | Alexion Pharmaceuticals, Inc. ($17,945) |
| 2023 | $36,031 | 197 | Alexion Pharmaceuticals, Inc. ($12,685) |
| 2022 | $22,137 | 93 | Alexion Pharmaceuticals, Inc. ($16,710) |
| 2021 | $6,450 | 20 | Alexion Pharmaceuticals, Inc. ($6,024) |
| 2020 | $9,579 | 24 | Alexion Pharmaceuticals, Inc. ($9,365) |
| 2019 | $9,022 | 86 | Alexion Pharmaceuticals, Inc. ($6,683) |
| 2018 | $1,425 | 65 | Amgen Inc. ($272.35) |
| 2017 | $163.69 | 9 | Mallinckrodt LLC ($45.25) |
All Payment Transactions
720 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: PAIN | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.82 | General |
| 12/16/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $48.27 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $77.33 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Analgesic | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.65 | General |
| 12/05/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/05/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: Neurology | ||||||
| 12/04/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $36.46 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Neurology | ||||||
| 12/01/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.73 | General |
| 11/26/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Neuroscience | ||||||
| 11/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Analgesic | ||||||
| 11/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 307 | 387 | $144,886 | $40,716 |
| 2022 | 8 | 255 | 298 | $82,705 | $31,237 |
| 2021 | 9 | 276 | 326 | $86,919 | $37,166 |
| 2020 | 8 | 219 | 269 | $62,899 | $25,218 |
Total Patients
1,057
Total Services
1,280
Medicare Billing
$134,337
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 70 | $21,910 | $9,423 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 76 | $16,096 | $7,022 | 43.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 48 | 80 | $60,000 | $6,216 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $13,230 | $5,225 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $11,542 | $4,698 | 40.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 30 | 30 | $12,000 | $4,059 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 46 | $6,808 | $2,983 | 43.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $3,300 | $1,090 | 33.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 55 | 85 | $24,078 | $6,944 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $16,002 | $6,392 | 39.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 36 | $10,243 | $4,892 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 56 | $11,570 | $4,877 | 42.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 18 | 18 | $7,072 | $2,608 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $5,144 | $2,310 | 44.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 17 | 17 | $5,068 | $1,882 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $3,528 | $1,333 | 37.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 61 | 93 | $18,507 | $8,001 | 43.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 49 | $13,524 | $6,306 | 46.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $13,373 | $5,569 | 41.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 25 | 25 | $9,800 | $4,553 | 46.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 48 | $9,840 | $4,231 | 43.0% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 14 | 14 | $6,566 | $2,664 | 40.6% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 22 | 22 | $6,556 | $2,501 | 38.2% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 15 | 15 | $5,880 | $2,380 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 17 | $2,873 | $960.39 | 33.4% |
About Ning Yang
Ning Yang is a Neuromuscular Medicine healthcare provider based in Greeley, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1275809675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ning Yang has received a total of $112,207 in payments from pharmaceutical and medical device companies, with $27,400 received in 2024. These payments were reported across 720 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,126).
As a Medicare-enrolled provider, Yang has provided services to 1,057 Medicare beneficiaries, totaling 1,280 services with total Medicare billing of $134,337. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromuscular Medicine
- Other Specialties Neurology
- Location Greeley, CO
- Active Since 03/29/2012
- Last Updated 03/17/2018
- Taxonomy Code 2084N0008X
- Entity Type Individual
- NPI Number 1275809675
Products in Payments
- ULTOMIRIS (Biological) $44,731
- Soliris (Drug) $11,474
- Rystiggo (Drug) $6,198
- VNS Therapy (Device) $1,098
- VYVGART (Drug) $1,029
- BRIUMVI (Drug) $825.54
- BOTOX (Biological) $714.02
- NURTEC ODT (Drug) $712.28
- SOLIRIS (Drug) $580.57
- SOLIRIS (Biological) $536.36
- VYEPTI (Biological) $482.93
- Aimovig (Biological) $454.24
- QULIPTA (Drug) $384.56
- VYVGART HYTRULO (Drug) $379.31
- AUBAGIO (Drug) $308.40
- EMGALITY (Drug) $268.59
- TYSABRI (Biological) $229.66
- Hizentra (Biological) $227.90
- UBRELVY (Drug) $224.74
- INGREZZA (Drug) $210.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.